FDA Adverse Event Injury Summary report: N

XACT CAROTID STENT SYSTEM

MDR report key: 1962146 · Received January 17, 2011

Report

Report Number
2024168-2011-00349
Event Type
Injury
Date Received
January 17, 2011
Date of Event
December 23, 2010
Report Date
December 23, 2010
Manufacturer
AV-TEMECULA-CT
Product Code
NIM
PMA / PMN Number
P040038
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
PA, US
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

(B)(4). DURING PROCESSING OF THIS COMPLAINT, ATTEMPTS WERE MADE TO OBTAIN COMPLETE EVENT, PATIENT AND DEVICE INFORMATION. BIVALIRUDIN, EMBOLIC PROTECTION: EMBOSHIELD NAV 6 ((B)(4), LOT 0081151) THERE WAS NO REPORTED PRODUCT DEFICIENCY. THE REPORTED PATIENT EFFECTS OF BRADYCARDIA, VASOCONSTRICTION, HYPOTENSION, CEREBROVASCULAR ACCIDENT AND TREATMENT WITH MEDICATIONS ARE KNOWN ADVERSE EVENTS AS LISTED IN THE PRODUCTS NO FAULT RISK ASSESSMENT REPORT. ADDITIONALLY, CEREBROVASCULAR ACCIDENT (STROKE), BRADYCARDIA, AND HYPOTENSION ARE LISTED IN THE PRODUCT INSTRUCTION FOR USE (IFU) AS KNOWN POTENTIAL ADVERSE EFFECTS. A CONCLUSIVE CAUSE FOR THE REPORTED PATIENT EFFECTS AND THE RELATIONSHIP TO THE DEVICE, IF ANY, CANNOT BE DETERMINED, THERE IS NO INDICATION OF A PRODUCT QUALITY DEFICIENCY WITH RESPECT TO MANUFACTURE OR DESIGN.

Description of Event or Problem · 1

IT WAS REPORTED THAT POST SUCCESSFUL XACT STENT IMPLANTATION IN THE RIGHT INTERNAL CAROTID ARTERY THE PATIENT EXPERIENCED A STROKE WITH LEFT SIDED PARALYSIS AND NUMBNESS, AND SPEECH DIFFICULTY ASSOCIATED WITH CAROTID SPASM, HYPOTENSION, AND BRADYCARDIA. DOPAMINE WAS STARTED AND THE SYMPTOMS MARKEDLY IMPROVED, ALTHOUGH SOME NEUROLOGIC DEFICITS CONTINUE. THOUGH REQUESTED, NO ADDITIONAL INFORMATION WAS PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 XACT CAROTID STENT SYSTEM CAROTID STENT SYSTEM NIM AV-TEMECULA-CT 526793

Patients

Seq Age Sex Outcome Treatment
1 82 YR Hospitalization| R| S